Gut microbiota is emerging as a novel risk factor for atherothrombosis, but the predictive role of gut-derived lipopolysaccharide (LPS) is unknown. We analyzed (1) the association between LPS and major adverse cardiovascular events (MACE) in atrial fibrillation (AF) and (2) its relationship with adherence to a Mediterranean diet (Med-diet).
Gut-Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet / Pastori, Daniele; Carnevale, Roberto; Nocella, Cristina; Novo, Marta; Santulli, Maria; Cammisotto, Vittoria; Menichelli, Danilo; Pignatelli, Pasquale; Violi, Francesco. - In: JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE. - ISSN 2047-9980. - 6:6(2017). [10.1161/JAHA.117.005784]
Gut-Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet
Pastori, Daniele;Carnevale, Roberto;Nocella, Cristina;Novo, Marta;Santulli, Maria;Cammisotto, Vittoria;Menichelli, Danilo;Pignatelli, Pasquale;Violi, Francesco
2017
Abstract
Gut microbiota is emerging as a novel risk factor for atherothrombosis, but the predictive role of gut-derived lipopolysaccharide (LPS) is unknown. We analyzed (1) the association between LPS and major adverse cardiovascular events (MACE) in atrial fibrillation (AF) and (2) its relationship with adherence to a Mediterranean diet (Med-diet).| File | Dimensione | Formato | |
|---|---|---|---|
|
Pastori_Gut-Derived Serum Lipopolysaccharide_2017.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
981.24 kB
Formato
Adobe PDF
|
981.24 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
